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Hepatitis B surface antigen (HBsAg) is the major component of the envelope of hepatitis B virus (HBV). As a resident 
membrane protein in the endoplasmic reticulum, it plays a key role in the viral morphogenesis. Little is known about 
cellular proteins that interact with HBsAg and thereby contributing to HBV morphogenesis. Using the yeast split-
ubiquitin system, a number of cellular membrane proteins have been isolated in this study. These include a resident 
protein of endoplasmic reticulum (thioredoxin-related transmembrane protein 2), an adaptor protein involved in 
clathrin-mediated endocytosis and HIV-mediated downregulation of CD4, and a co-receptor of coxsakie B virus. The 
significance of our findings is suggested by the identification of cellular membrane proteins interacting with other virus 
proteins. Further functional analysis of these HBsAg- interacting cellular membrane proteins should shed new insights 
on their role in HBV morphogenesis.     
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1.  Introduction 
Hepatitis B virus (HBV) is a small DNA virus 
consisting of a nucleocapsid which protects the 3.2 kb 
viral genome [1]. The nucleocapsid is surrounded by an 
envelope in which the major protein component is the 226 
amino acid hepatitis B surface antigen (HBsAg). In 
addition to its involvement as an envelope protein of the 
infectious HBV particles, HBsAg is capable of forming 
into lipoprotein subviral particles (without the 
nucleocapsid and HBV genome) that are secreted from 
infected cells. Inappropriate secretion of HBsAg subviral 
particles with notably its intracellular storage has been 
clinically implicated in the pathogenesis of chronic 
hepatitis B [2]. 
One important step in HBV replication cycle is the 
viral morphogenesis, particularly the interaction between 
the nucleocapsid and HBsAg anchored at the endoplasmic 
reticulum, leading to envelopment and secretion of 
mature HBV particles [3]. Despite the recently reported 
investigation on the role of chaperones [4], little is known 
about general network of host cellular proteins that is 
needed for HBV morphogenesis. While conventional yeast 
two hybrid screening has been successful in isolating 
soluble cellular proteins interacting with a bait of interest 
[5], it can not be applied in the isolation of those 
interacting with transmembrane bait proteins such as 
HBsAg. 
A yeast split-ubiquitin screening system for the 
characterization of membrane protein-protein interactions 
has been described [6-8]. We report in this study the 
application of this system to identify cellular membrane 
proteins interacting with HBsAg. The significance of our 
finding in the perspective of better understanding HBV 
morphogenesis is discussed.  
2.  Materials and methods 
Plasmids and reagents were contained in 
DUALmembrane Kit (DUALSystems Biotech, 
Switzerland). 
2.1 Amplification and Cloning of HBsAg 
The 678bp HBsAg gene was amplified by PCR using 
full length HBV DNA (adw2 serotype) as the template. The 
oligonucleotide primers were designed as follows: 
5’-TTAGGCCTAAAAATGGAGAACATCACATCAGGA-3’ 
5’-AAAACAGAGACCCATATGTAAATTGGTACCAATT-3’ 
The amplified PCR product was cloned into the 
binding domain vector pTMBV4 in-frame with Cub (the 
yeast ubiquitin). The construct was then used to transform 
yeast S. cerevisiae DSY-1 strain by LiOAc method.  
2.2 Construction of cDNA Library from HBV-transfected 
HepG2 Cells 
2.2.1 Cell Culture and Transfection 
Human hepatomacellular carcinoma cell line, 
HepG2, was grown in 12ml Dulbecco’s Modified Eagle’s 
Medium (DMEM) (Gibco) supplemented with 20% fetal 
calf serum and maintained in a saturated, humidified 
environment of 5% CO2 and 95% air at 37oC. The cell 
density when confluent was approximately 2 x 106 HepG2 
cells per 100mm dish. The replicative HBV genome was 
constructed by cloning a linear form of viral genome into 
mammalian expression vector pcDNA3.1 [9]. The linear 
genome, containing the viral promoter at its 5’ end and 
the region for termination of transcription at its 3’ end, 
was then transfected into these cells as described [9]. The 
ability of this genome in behaving as a replicative virus 
was assessed by the amount of HBsAg particles produced 
in the cell culture medium two days after its transfection 
into HepG2 cells, using ImX semi-quantitative 
measurement (Abbott Laboratories, USA).  
Total RNA was extracted from these HBV-
transfected HepG2 cells, and used as template for the Int. J. Med. Sci. 2005 2  115
synthesis of cDNA. The first strand cDNA was generated 
using random hexamer primer from BD Matchmaker™ 
Library Construction & Screening Kits User Manual (BD 
Biosciences, Clontech, USA). The second strand cDNA 
was synthesized using Long-Distance PCR (LD-PCR). The 
PCR mixture containing double stranded cDNA was 
purified using BD CHROMA SPINTM TE-400 Column.  
2.2.2 Construction of cDNA Library in S. cerevisiae DSY-2 Strain  
The cDNA library was prepared by transforming the 
yeast  S. cerevisiae DSY-2 strain, in which the cDNA 
mixture was combined with pDL2-XN vector through 
homologous recombination. Yeast colony PCR was done 
f o r  2 2  r a n d o m l y  p i c k e d  c o l o n i e s  t o  a s s e s s  t h e  s i z e  o f  
cDNA insert. For each colony picked, half was streaked on 
SD/-Trp plate and the other half inoculated into a 20µl 
PCR mix.  
Three ml of the freezing medium (SD/-Trp, 15% 
glycerol) was added to each plate and the yeast colonies 
were dislodged off the plates using a sterile loop. The 
suspension from each plate was then pooled together into 
a 1-litre sterile conical flask. The pooled suspension was 
given a mix by swirling before aliquoting into Falcon 
tubes proportionally for centrifugation at 700 x g for 5 
minutes. The supernatant was discarded and the pellet 
was resuspended in half the original volume using 
Freezing medium. 1ml of cells were then aliquoted into 
ten 1.5ml microcentrifuge tubes, 10ml of cells were 
aliquoted into five 15ml tubes and the remaining cells 
aliquoted into 50ml Falcon tubes. The samples were then 
stored at -80oC. 
2.3 Split-Ubiquitin Yeast Two Hybrid Screening 
2.3.1 Mating of S. cerevisiae DSY-1 (Bait) and S. cerevisiae DSY-2 
(Prey) 
The 1ml aliquot (≥2x107 cells) frozen cDNA library 
was added to 5ml bait cells in a sterile 3-litre conical flask. 
The mixture was incubated at 30oC for 24 hours with 
gentle swirling at 30rpm. After 20 hours of mating, a drop 
of the mating culture was checked under a phase-contrast 
microscope at 400X magnification to check for the 
presence of 2 haploids. The culture was split into two 
50ml Falcon tubes and centrifuged at 1000 x g for 10 
minutes. The 3-litre flask used for mating was rinsed 
twice with 50ml of 0.5X YPDA/Kanamycin (50µg/ml) per 
rinsed. Each rinse (50ml) was used to resuspend one 
pellet. After resuspension, the tubes were centrifuged at 
1000 x g for 10 minutes and the supernatant discarded. 
The pellet was resuspended in 5ml 0.5X 
YPDA/Kanamycin (50µg/ml) and combined into a total 
volume of 10ml. 
To calculate the mating efficiency, 100µl of a 1: 10 
000, 1: 1 000, 1: 100 and 1:10 dilutions of the mating 
mixture was spread onto SD/-Leu, SD/-Trp and SD/-
Leu/-Trp agar plates. The remaining mating mixture was 
distributed evenly onto 5mM TDO-3AT plates with 
plating volume of 200µl. The plates were sealed and 
placed in a 30oC incubator for approximately 7 days. 
2.3.2 Selection for S. cerevisiae Diploids Expressing Interacting 
Proteins 
A total of fifteen colonies were selected for the first 
round of screening. Half of the colony was streaked on 
SD/-Trp agar plate and the other half inoculated into 20µl 
of PCR mix. PCR products were sequenced to determine 
the identity of the interacting proteins.  
3.  Results and Discussion 
3.1 Principle of Split-Ubiquitin Screening System 
Studies have shown that the use of yeast two hybrid 
system, which is a genetic assay for in vivo detection of 
interactions of proteins, enables identification of protein-
protein interactions between a soluble bait and its 
interacting prey [5]. However, such a screening system is 
not suitable for the analysis of interaction between 
membrane bound proteins.  
The split-ubiquitin yeast two hybrid system has been 
recently developed for the characterization of membrane 
protein interactions to overcome this limitation [6-8]. In 
this system, the ubiquitin is split into N-terminal ubiquitin 
(Nub) and C-terminal ubiquitin (Cub) but the Nub and 
Cub have high affinity towards each other and is able to 
reassemble back together spontaneously into ubiquitin 
protein. When Nub and Cub moieties bind together 
within a cell, this would activate the ubiquitin-specific 
protease (UBP) and hence, the transcriptional factor (TF) 
will be cleaved off. The cleaved TFs such as protein A-
LexA-VP16 (PLV) will activate the expression of reporter 
genes (LacZ  and  HIS3) in the nucleus. The interaction 
between various membrane proteins will then be reflected 
by the activity of these reporter gene products, which can 
be measured similarly to the conventional yeast two 
hybrid system.   
The bait protein, which is the HBsAg, is fused to a 
vector (pTMBV4) containing the Cub-reporter protein 
complex. The prey protein, which is the human malignant 
liver HepG2 cell transfected with HBV adw2 serotype, is 
fused to vector (pDL2-XN) which contains a mutated 
NubG domain. The fusion plasmids are then cloned into 
the yeast cell and expressed on the cell membrane. If the 
prey protein interacts with the bait protein, this would 
bind the NubG and Cub domains together to form the 
ubiquitin complex. 
This complex will then be recognized by UBPs and 
the TF that is located at the C terminus of Cub will be 
cleaved off and result in downstream reactions, which is 
the activation of LacZ and HIS3 reporter genes [7]. 
3.2 Identification of Cellular Membrane Proteins 
Interacting with HBsAg 
A number of cellular proteins have been isolated 
using the conventional yeast two hybrid screening [10, 
11]. However, these reported HBV interacting proteins 
have all been isolated from normal liver cells that had not 
been exposed to HBV, which may reflect physical but 
physiologically not meaningful interactions. There is 
therefore a need to comprehensively isolate and 
characterize, in an environment, cellular proteins 
interacting not only with soluble HBV proteins, but also 
with membrane bound HBsAg. 
To this end, a linearised form of HBV genome has 
been constructed in the mammalian expression vector 
pcDNA3.1 [9]. The linear HBV genome contained the viral 
promoter at its 5’ end and the region for termination of 
transcription at its 3’ end [9]. The ability of this genome in 
behaving as a replicative virus after its transfection in 
HepG2 cells was then measured by the amount of HBsAg 
particles secreted into cell culture medium two days after 
its transfection. Using the ImX semi-quantitative 
measurement, results in Table 1 suggested that HBsAg 
produced in the culture medium (rate of 65.8) was 
significantly higher than the negative control (normal Int. J. Med. Sci. 2005 2  116
culture medium with a rate of 4.3), but lower than the 
positive control (rate of 221.4). Our results suggested that 
a cellular environment exposed to HBV could be 
generated by transfecting a replicative HBV genome. 
Table 1. Semi-Quantitative Measurement of HBsAg Following 
HBV-Transfection 
  Reaction Rate / Reactivity 
Replicative HBV Genome  65.8 / Reactive 
Positive Control  221.4 / Reactive 
Negative Control  4.3 / Non-Reactive 
 
A cDNA library was therefore constructed from 
HBV-transfected HepG2 cells, using homologous 
recombination in yeast. PCR analysis on randomly 
selected colonies revealed a wide range of inserts from 250 
bp (lanes, 2, 6 and 8, Fig. 1) to 1,500 bp (lane 10 and 13, 
Fig. 1). In addition, cDNA insert was detected in all 
selected colonies except colony 14. The wide range of 
cDNA inserts and absence of empty vector as shown in 
Fig. 1 indicated that the cDNA library constructed in this 
study was suitable for the screening of cellular proteins 
interacting with HBsAg. 
Figure 1. Determination of Size of Inserts in cDNA Library 
Constructed from HBV-transfected HepG2 Cells. The 
construction of this cDNA library from HBV-infected HepG2 
cells was described in MATERIALS AND METHODS. Yeast 
colonies were selected randomly for PCR amplification. Size of 
individual inserts reflected by the size of the amplified PCR 
product was analysed on an agarose gel. Lane 1 to 22, PCR 
product from each of the 22 randomly selected colonies. Lane 1 
kb DNA Ladder, DNA molecular weight marker.   
 
 
With HBsAg as bait, fifteen colonies were obtained 
from screening the above cDNA library using the yeast 
split-ubiquitin system. Sequence analysis revealed three 
interacting cellular membrane proteins as summarized in 
Table 2. 
Table 2. Summary of Cellular Membrane Proteins Interacting 
with HBsAg 
Clone Cellular  Membrane 
Protein 
Function Reference 
1 Thioredoxin-related 
transmembrane protein 2 
(trx2) 
Stimulate cell growth 
and prevent apoptosis 
[12, 13] 
3 Adaptor-related  protein 
complex 2 (AP-2) 
Clathrin-mediated 
endocytosis and protein 
sorting 
[14, 15] 
4  Decay accelerating factor 
for complement (DAF) 
Regulation of 
complement activation 
and virus co-receptor 
[16, 17] 
 
While the role of the ER resident protein trx2 [13] in 
HBV morphogenesis remains to be elucidated, AP-2 and 
DAF have been implicated in virus infections [15, 17]. A 
major component of clathrin-associated adaptor protein 
complex that is involved in the clathrin-mediated 
endocytosis [14], AP-2 has also been involved in the 
downregulation of CD4 and MHC class I molecules by nef 
(a regulatory protein of HIV) thereby resulting in an 
increased HIV virulence [15]. On the other hand, the 
decay-accelerating factor (DAF) with its well-established 
role in the inhibition of activation of complement cascade 
[16] has recently been shown to be a co-receptor for 
coxackie B virus and involved in the transcytosis of the 
virus [17]. Further functional analysis of these HBsAg-
interacting cellular membrane proteins should shed new 
insights on their role in HBV morphogenesis.    
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